Skip to main content

Fideres Advises In Y-mAbs Therapeutics Securities Expert Report

Dr. Matthew D. Cain filed his class certification analysis in Rodriguez v. Y-mAbs Therapeutics Inc. (Case No. 1:20-cv-10955), with statistical research and econometric modeling support from Fideres.

Cain’s evaluation examines whether Y-mAbs securities operated in an efficient market where material disclosures were rapidly incorporated into stock valuations. Fideres performed detailed event study analysis and volatility modeling, utilizing advanced statistical methods to isolate disclosure-specific price effects from broader market movements.

The expert analysis identified statistically significant abnormal returns during key disclosure periods, with quantitative evidence demonstrating rapid price discovery following material information releases.